| Identification | Back Directory | [Name]
Bosentan Impurity 1 | [CAS]
1218951-81-5 | [Synonyms]
N,N'-(5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6-diyl)bis(4-(tert-butyl)benzenesulfonamide)
N,N'-[5-(2-Methoxyphenoxy)[2,2'-bipyrimidine]-4,6-diyl]bis[4-(1,1-dimethylethyl)benzenesulfonamide | [Molecular Formula]
C35H38N6O6S2 | [MOL File]
1218951-81-5.mol | [Molecular Weight]
702.84 |
| Chemical Properties | Back Directory | [Boiling point ]
810.1±75.0 °C(Predicted) | [density ]
1.316±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [pka]
3.63±0.10(Predicted) | [Major Application]
pharmaceutical small molecule |
| Hazard Information | Back Directory | [Uses]
N,N''-[5-(2-Methoxyphenoxy)[2,2''-bipyrimidine]-4,6-diyl]bis[4-(1,1-dimethylethyl)benzenesulfonamide] is the impurity of the drug Bosentan (B675900), which is a mixed endothelin receptor antagonist that is used as vasodilator; antihypertensive. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|